Stockreport

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

ImmuCell Corporation  (ICCC) 
US:NASDAQ Investor Relations: immucell.com/investors
PDF PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, ma [Read more]